Cytovale's Rapid Diagnostic Slashes Sepsis Mortality by 39%, Peer-Reviewed Study Confirms
One of the largest real-world studies of a sepsis diagnostic reveals that Cytovale'sReadmore
This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
An unforgettable learning experiences!!!
You will hear key opinion leaders discuss vital developments and challenges and participate in activities, polls, and Q&As during the interactive sessions.
Each year, 26 million people worldwide suffer from sepsis with an average of six million deaths. It is the primary cause of death from infection and is more common than heart attacks. In fact, sepsis is a contributing factor in one third of all hospital deaths.
Sciinov Group, is excited to announce the Global Congress on 3rd Edition: SEPSIS & WOUND CARE...
Will be bringing you the latest scientific research, clinical best practice and an opportunity to network
We are always looking for new industry leaders to join our speaker faculty to deliver presentations, lead panel discussions and moderate sessions or roundtables.
If you are interested in being considered as a speaker, submit your proposal/abstract Online
We let speakers propose the topic they want to talk about. This process allows speakers to propose sessions that speak from their expertise and passion.
Speaker can choose the topic of your choice in related to the conference subject or any of their recent research work to present at our conference.
For details of scientific sessions covered please visit [not limited to, you can propose]
Please visit the page here
Yes, as our conference is scheduled in Hybrid Mode, you can present and listen to full program virtually connecting via ZOOM live stream
June 12
2025
Cytovale's Rapid Diagnostic Slashes Sepsis Mortality by 39%, Peer-Reviewed Study Confirms
One of the largest real-world studies of a sepsis diagnostic reveals that Cytovale'sReadmore
May 28
2025
New ‘superbug’ antibiotic to treat sepsis and pneumonia enters last phase of testing
A new antibiotic, Zolafren, has entered its final trial phase to treat deadly drug-resistant infections like sepsis and pneumonia. Early results show high effectiveness, raising hopes for a powerful new tool against superbugsReadmore
June 13
2025
Global action urgently needed to tackle antimicrobial resistance, experts warn
Researchers from King’s College London have called for urgent changes to the way new antibiotics are developed to address the growing problem of antimicrobial resistance (AMR).Readmore
May 27
2025
Her patient had pneumonia but died of sepsis — a fast-moving, deadly condition where the body attacks itself in response to infection. Quick diagnosis is critical, but doctors still lack accurate tools to predict it early.Readmore
Thank you very much for the organization of such an event. I have learned a lot.
Congratulations on the great turnout at the Aging and Gerontology Conference this year!!! I really enjoyed presenting at your event
It was a great experience exchanging views on Aging with speakers from all around the world.
Good day a very nice and informative congress, most of the presentations were very interesting. As a clinical medical doctor i hope some of them can help me in my daily private practice and institutional one. Besides congratulate you for the quality of the Keynote and oral presentations.
Global
Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology (Microbiology, Immunoassays), By Pathogen, By Method, By End-user, And Segment Forecasts, 2023 - 2030
Global
Advanced Wound Care Market by Product (Infection Management, Exudate Management, Active Wound Care, and Therapy Devices), Application (Chronic Wounds and Acute Wounds), and End User (Hospitals and Community Health Service Centers): Global Opportunity Analysis and Industry Forecast, 2021-2030
Global
Chronic Wound Care Market Size by Product (Surgical & Traditional Wound Care, Wound Therapy Devices, and Advanced Wound Dressing), Type (Venous Ulcers, Pressure Ulcers, Diabetic Ulcers, and Others) End-Use (Homecare Settings, Hospitals, Wound Care Centers, and Others), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2031
Global
Global wound care market in terms of revenue was estimated to be worth $20.8 billion in 2022 and is poised to reach $27.2 billion by 2027, growing at a CAGR of 5.4% from 2022 to 2027